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Abstract
Background: Inflammatory bowel disease (IBD) is being increasingly diagnosed in Asia. However there are few
epidemiological data from the region.
Methods: To determine prevalence and clinical characteristics of IBD, a hospital-based survey was performed in
the Colombo and Gampaha districts (combined population 4.5 million) in Sri Lanka. Patients with established
ulcerative colitis (UC) and Crohn’s disease (CD), who were permanent residents of these adjoining districts, were
recruited from hospital registries and out-patient clinics. Clinical information was obtained from medical records
and patient interviews.
Results: There were 295 cases of IBD (UC = 240, CD = 55), of which 34 (UC = 30, CD = 4) were newly diagnosed
during the study year. The prevalence rate for UC was 5.3/100,000 (95% CI 5.0-5.6/100,000), and CD was 1.2/100,000
(95% CI 1.0-1.4/100,000). The incidence rates were 0.69/100,000 (95% CI 0.44-0.94/100,000) for UC and 0.09/100,000
(95% CI 0.002-0.18/100,000) for CD. Female:male ratios were 1.5 for UC and 1.0 for CD. Mean age at diagnosis was
(males and females) 36.6 and 38.1y for UC and 33.4 and 36.2y for CD. Among UC patients, 51.1% had proctitis and
at presentation 58.4% had mild disease. 80% of CD patients had only large bowel involvement. Few patients had
undergone surgery.
Conclusions: The prevalence of IBD in this population was low compared to Western populations, but similar to
some in Asia. There was a female preponderance for UC. UC was mainly mild, distal or left-sided, while CD mainly
involved the large bowel.
Background
Inflammatory bowel disease (IBD) includes ulcerative
colitis (UC) and Crohn’s disease (CD), which are
chronic inflammatory diseases of the gastrointestinal
tract. The underlying aetiology and pathogenesis of IBD
remains largely unknown, but are thought to result from
an interaction between genetic susceptibility, environ-
mental factors and the host immune response. IBD has
been regarded as a disease primarily occurring in Wes-
tern populations. High prevalence rates have been
reported from North America, United Kingdom, and
Northern Europe [1-3]. Although it was earlier consid-
ered rare in Asia [4-6], a number of recent reports
suggest an increase in the incidence and the prevalence
of IBD in the region [7-13]. Although better diagnostic
awareness and increasing access to modern endoscopic
technology may play a role, these factors alone are unli-
kely to explain this increase. Reasons for the increasing
i n c i d e n c eo fI B Di nA s i aa r ep r o b a b l ym u l t i - f a c t o r i a l ,
and may at least partly be related to development and
prosperity, resulting in improved hygiene and changing
dietary habits [14]. Investigating the early stages of IBD
as it emerges in new populations may provide a new
opportunity to study its pathophysiology.
Unfortunately, data on the epidemiology and clinical
characteristics of IBD in many Asian countries, and for
that matter in most developing countries, are scarce
[13]. Epidemiological and clinical information on IBD in
many of these countries suffer from poor reporting
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from undefined catchment areas, and non-uniform diag-
nostic criteria. There are also problems in diagnosis due
to lack of awareness, poor resources, and problems of
differentiating IBD from intestinal infections; circum-
stances where accurate incidence and prevalence figures
are difficult to derive [14].
Sri Lanka is a country in economic transition, and dis-
ease patterns reflect this; there has been a gradual
decline in diseases associated with poverty and an
increase in non-communicable diseases. The epidemiol-
ogy of IBD in Sri Lanka has not been investigated. We
conducted a study to determine the prevalence and clin-
ical characteristics of IBD in the Colombo and Gampaha
districts of Sri Lanka. These two adjoining districts were
selected as they appeared to be best suited for a hospital
based survey: the two districts have a well defined catch-
ment area for the regional hospitals; they are the most
developed and populous in Sri Lanka; they have a rea-
sonable ethnic and urban-rural mix, and high literacy
rates (>95%) which would positively impact on health
seeking behaviour [15].
Methods
Study population
A hospital-based survey was performed over a period of
one year from December 2007 to November 2008 in the
Colombo and Gampaha districts of Sri Lanka. The com-
bined population of the two districts is approximately
4.5 million [14], and is served by 24 state sector hospi-
tals (that offer free health care); 10 offering specialist
services and 14 that do not (Figure 1). As the most
urbanised and developed districts with the highest level
of health care in the country it can be assumed that the
population of these adjoining districts is stable.
Sampling and subject recruitment
A preliminary survey, by telephone interview, was con-
ducted among Medical Officers-in-Charge of the 14
hospitals in the two districts which do not offer specia-
list services. Patients suspected to have IBD had been
encountered in 5 of these 14 hospitals. However, none
of the non-specialist hospitals treated or followed-up
IBD patients, and always referred suspected cases to the
10 specialist hospitals. Therefore, only the 10 specialist
hospitals in the two districts were included in the hospi-
tal survey.
Patient registries in the selected hospitals were exam-
ined, and patients with established IBD who were per-
manent residents in the two districts were recruited.
The diagnosis of IBD had to satisfy accepted clinical,
radiological and endoscopic criteria with histological
confirmation [16]. Patient identities were cross-checked
to avoid replication. Clinical information was obtained
by both review of case records and patient interviews
after written informed consent. The following informa-
tion was obtained: demographic characteristics, age at
diagnosis, clinical presentation, duration of disease,
family history of IBD, extent (assessed by colonoscopy,
small bowel studies, and histology) and severity
(assessed by endoscopy and histology according to the
opinion of the investigators) of the disease at the time
of diagnosis, presence of extra-intestinal manifestations,
treatment modalities and the requirement for surgical
intervention. The anatomical extent of UC as deter-
mined by the first-time colonoscopy was classified as
distal colitis (limited to the rectum and sigmoid colon),
left-sided colitis (disease distal to the splenic flexure) or
“extensive” colitis (extending proximal to the splenic
flexure) [17]. The extent of CD, was determined by
endoscopic and radiological methods, and was classified
as upper gastrointestinal, small bowel, large bowel and
ano-rectal disease.
The population figures and other demographic data
for the two districts were obtained from the Department
of Census and Statistics of Sri Lanka [15]. The preva-
lence rates of UC and CD were calculated using the
total number of residents in the two districts (catchment
area) as the denominator and the total number of
patients with UC and CD respectively as the numera-
tors. The incidence rates were calculated using the num-
ber of new cases diagnosed during the year of the study
as the numerators.
Statistical analysis
The crude prevalence and incidence rates for UC and
CD were calculated. The rates were expressed as num-
ber of patients per 100,000 population. Ninety five per-
cent confidence intervals (95% CI) for prevalence and
incidence rates were estimated.
Ethics
E t h i c a la p p r o v a lf o rt h es t u d yw a so b t a i n e df r o mt h e
Ethical Review Committee of the Faculty of Medicine,
University of Kelaniya.
Results
There were 295 confirmed cases of IBD (UC = 240, CD
= 55). Of these, 34 cases (UC = 30, CD = 4) were newly
d i a g n o s e dd u r i n gt h es t u d yy e a r .T h ep r e v a l e n c eo fU C
was 5.3/100,000 (95% CI 5.0-5.6/100,000) and CD was
1.2/100,000 (95% CI 1.0-1.4/100,000). The incidence of
UC was 0.69/100,000 (95% CI 0.44 - 0.94/100,000) and
CD was 0.09/100,000 (95% CI 0.002-0.18/100,000). Age
related prevalence for UC and CD are given in Figure 2.
Among 295 confirmed cases of IBD, the female:male
ratios for UC and CD were 1.5 and 1.0 (Table 1). This
trend for female preponderance in UC was observed in
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(Table 2). Of patients with UC, 89.7% were Sinhalese,
7.3% Tamil and 3% Muslim. 90.9% with CD were Sinha-
lese, 7.3% Tamil and 1.8% Muslim. The observed differ-
ences in type, extent and severity of disease generally
reflected the districts’ ethnic demography (Table 3).
Mean age at diagnosis (males and females) for UC was
36.6 and 38.1 years, and for CD 33.4 and 36.2 years.
At the time of diagnosis, among UC patients, 51.1%
had proctitis, 22.6% left-sided disease and 26.3% exten-
sive disease [173 out of the 240 (72.1%) UC patients had
had a full colonoscopy to assess extent at the time of
diagnosis), and 58.4% had mild disease, 29.5% had mod-
erate disease, and 12.1% had severe disease. 80% of CD
patients had only large bowel involvement. 2.2% of UC
and 5.5% of CD patients had a positive family history.
40.4% of UC and 38.2% of CD patients had extra-intest-
inal manifestations. 4.7% of UC and 18.2% of CD
patients had undergone surgery.
Discussion
The present study, the first epidemiological study of IBD
in this country, showed that prevalence rates were 5.3/
100,000 for UC and 1.2/100,000 for CD. The incidence
rates were 0.69/100,000 for UC and 0.09/100,000 for
CD. The prevalence rates are low compared to Western
populations [1-3], but are comparable to many, but not
all, of the reported rates from Asia [14,18,19].
Figure 1 Map of Sri Lanka showing the locations of specialist and non-specialist hospitals in the Colombo and Gampaha districts.
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cal study for IBD should have a well-defined catchment
area and up-to-date population data, good diagnostic facil-
ities, uniform criteria of case definition, a common proto-
col and an established referral system [20]. Our study
satisfied several of the above criteria. The two districts
selected for the study have well defined catchment areas
for the regional hospitals. Only permanent residents of the
districts were included in the survey. As the most urba-
nised and developed districts in the country, demographic
data are up-to-date, staffing and diagnostic facilities in
hospitals among the best in the country. It is therefore
unlikely that there is significant migration to other parts of
the country for employment or health care. The high lit-
eracy rate of the population would also positively impact
on health seeking behaviour [15]. Based on the results of
the telephone interview of doctors in the smaller hospitals,
it was reasonable to assume that most if not all IBD
patients in the catchment area would be referred to specia-
lists for investigation and treatment. The need to select
only hospitals staffed by specialists would have improved
the accuracy and uniformity of the diagnosis of IBD, espe-
cially because bowel infections are common in countries
such as ours, and may trigger and alter the course of
underlying IBD [21,22]. However, there are limitations;
being a hospital based study the survey was limited to
symptomatic IBD patients seeking medical care, and direct
data collection was limited to patients seeking health care
in hospitals. Furthermore, patients who may have sought
alternative forms of treatment would have been excluded.
Table 1 Clinical characteristics of IBD patients
Ulcerative colitis
(UC) (N = 240)
Crohn’s disease (CD)
(N = 55)
Sex
Females 144 28
Males 96 27
Mean age at diagnosis
Females 38.1 33.4
Males 36.6 36.2
Ethnicity
Sinhalese 209 (89.7%) 50 (90.9%)
Tamil 17 (7.3%) 4 (7.3%)
Muslim 7 (3%) 1 (1.8%)
--
Extent of disease (UC-221)
Distal 113 (51.1%) -
Left-sided 50 (22.6%) -
Extensive 58 (26.3) -
Extent of disease (CD-55)
Only small intestinal involvement - 7 (12.7%)
Only large intestinal involvement - 44 (80%)
Large & small intestinal involvement - 4 (7.3%)
Perianal disease - 4 (7.3%)
Upper gastrointestinal involvement - 3 (5.5%)
Severity of disease (UC-166) (CD-45)
Mild 97 (58.4%) 26 (57.7%)
Moderate 49 (29.5%) 10 (22.2%)
Severe 20 (12.2%) 9 (20%)
Extra-intestinal manifestations
Arthralgia and arthritis 68 (28.3%) 13 (23.6%)
Ocular disease 22 (9.2%) 9 (16.4%)
Skin rashes 18 (7.5%) 3 (5.5%)
Backache 17 (7.1%) 3 (5.5%)
Positive family history 5 (2.1%) 3 (5.5%)
Surgical intervention 11 (4.6%) 10 (18.2%)
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the true incidence and prevalence of IBD in the districts.
We observed several differences in the clinical character-
istics of IBD in our patients compared to Western patients.
These may well be due to IBD in Asians being genetically
and phenotypically different to IBD in Western populations.
There was an overall female predominance for UC (F: M =
1.5:1) but no racial differences in prevalence. This is in con-
trast to reports from Western and most Asian countries
where there is no sex difference. The mean age at diagnosis
of our patients was slightly older than that observed in
Western [3] and some other Asian studies [9-13]. This may
be due to late presentation at the specialist hospital, but
could also reflect milder disease in this cohort. IBD was
uncommon among our children, unlike in Western series.
Many Western studies have found a so-called ‘second peak’
of prevalence for UC in the over-65s. Our patient popula-
tion showed peak prevalence in the fourth decade. The
apparent bimodal age distribution (Figure 2) is in agree-
ment with Western studies [23], but is difficult to draw
firm conclusions on because of the relatively small number
of UC patients and even smaller number of CD patients in
our study. A family history for both UC and CD was
uncommon, and may indicate a lesser genetic predisposi-
tion to the disease than in Western populations, but time
trend studies of the prevalence of IBD are necessary to
investigate this further. Most of our patients with UC had
mild, distal or left sided disease clinically and endoscopi-
cally, and responded well to medical treatment, with only a
few patients requiring surgical intervention. Many of our
observations are similar to those in previous reports of UC
from the Asian region [7,24,25].
Conlusion
The prevalence of UC and CD in this hospital based
study was low compared to Western populations, but
similar to some in Asia. Many features of IBD were
similar to IBD in the West, but there were notable dif-
ferences: there was a female preponderance for UC
although there were no racial differences; IBD com-
m o n l yp r e s e n t e di nt h ef o u r t hd e c a d eo fl i f ea n dw a s
uncommon in children; only few of our patients had a
family history; and most patients with UC had mild, dis-
tal or left sided disease. Investigating these differences
as IBD emerges in developing countries may give further
clues to its aetio-pathogenesis.
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